Library
PubMed
research article
Professional

Sustainable Desalination in the Persian Gulf: A Comprehensive Environmental and Economic Assessment of a High-Efficiency Reverse Osmosis System.

Source: PubMed, NCBI / U.S. National Library of Medicine

Integrated environmental assessment and managementJahish Abdul Nasir, Nowrouzi Mohsen, Abyar HajarPublished 5/25/2026Last synced 6/4/2026Status: syncedPMID: 42185075DOI: 10.1093/inteam/vjag025

Water supply through economically and environmentally friendly approaches, especially in areas facing a water crisis, is one of the most pressing global challenges. The present study proposes a highly efficient reverse osmosis (RO) system for desalinating Persian Gulf water and explores its environmental impacts, energy efficiency, cost-effectiveness, and operational consistency. The designed RO system significantly decreased ionic concentration (90%), TDS (99.6%), electrical conductivity (99.4%), and NaCl (>95%). The life cycle assessment was conducted using the production of 1&#x2009;m3 of potable water via reverse osmosis desalination of Persian Gulf seawater as the functional unit. The highest environmental burdens appeared to be human carcinogenic toxicity (48%) and freshwater ecotoxicity (19%), mainly from Mg2+, NO3-, and Cl- releases. The RO system adversely affected human health (96.33%) and ecosystems (2.35%) because of effluent and energy consumption, whereas fossil fuels dominated the resource category. Fossil fuels supplied 93.7% of the system's energy requirements, leading to 99.8% of the overall greenhouse gas emissions, specifically CO2 (70.65%) and CH4 (10.8%). Sensitivity analysis revealed that a 20% reduction in Mg2+ and NO3- inputs alleviated impacts by 43.81% to 95.21% across all categories. Furthermore, the Monte Carlo simulation revealed a coefficient of variation of&#x2009;<10% for all environmental categories, confirming the credibility and reliability

Abstract

Water supply through economically and environmentally friendly approaches, especially in areas facing a water crisis, is one of the most pressing global challenges. The present study proposes a highly efficient reverse osmosis (RO) system for desalinating Persian Gulf water and explores its environmental impacts, energy efficiency, cost-effectiveness, and operational consistency. The designed RO system significantly decreased ionic concentration (90%), TDS (99.6%), electrical conductivity (99.4%), and NaCl (>95%). The life cycle assessment was conducted using the production of 1&#x2009;m3 of potable water via reverse osmosis desalination of Persian Gulf seawater as the functional unit. The highest environmental burdens appeared to be human carcinogenic toxicity (48%) and freshwater ecotoxicity (19%), mainly from Mg2+, NO3-, and Cl- releases. The RO system adversely affected human health (96.33%) and ecosystems (2.35%) because of effluent and energy consumption, whereas fossil fuels dominated the resource category. Fossil fuels supplied 93.7% of the system's energy requirements, leading to 99.8% of the overall greenhouse gas emissions, specifically CO2 (70.65%) and CH4 (10.8%). Sensitivity analysis revealed that a 20% reduction in Mg2+ and NO3- inputs alleviated impacts by 43.81% to 95.21% across all categories. Furthermore, the Monte Carlo simulation revealed a coefficient of variation of&#x2009;<10% for all environmental categories, confirming the credibility and reliability of the results. The water production, capital, and operating expenses were calculated as $0.10/m&#xb3;, $74,908.2/m&#xb3;, and $409,687,014.2, respectively. Over a 20-year period, the net present value obtained was $1,984,510,642 with an 11-year payback period. Collectively, implementing an appropriate pretreatment and using renewable energy sources notably reduces the carbon footprint of RO system (>60%). The current investigation highlights the role of management strategies in mitigating the environmental impacts of RO systems.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.